Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Taiga Ichinomiya is active.

Publication


Featured researches published by Taiga Ichinomiya.


Cardiovascular Diabetology | 2012

High-dose fasudil preserves postconditioning against myocardial infarction under hyperglycemia in rats: role of mitochondrial KATP channels

Taiga Ichinomiya; Sungsam Cho; Ushio Higashijima; Shuhei Matsumoto; Takuji Maekawa; Koji Sumikawa

BackgroundThe current study was carried out to determine whether fasudil hydrochloride (fasudil), a Rho-kinase inhibitor, has myocardial postconditioning (PostC) activity under hyperglycemia as well as normoglycemia, and if so, whether the effects could be mediated by mitochondrial ATP-sensitive potassium (m-KATP) channels.MethodsMale Sprague-Dawley rats were anesthetized with sodium pentobarbital. After opening the chest, all rats underwent 30-min coronary artery occlusion followed by 2-h reperfusion. The rats received low-dose (0.15 mg/kg) or high-dose (0.5 mg/kg) fasudil or diazoxide, an m-KATP channel opener, at 10 mg/kg, just before reperfusion under normoglycemic or hyperglycemic conditions. In another group, rats received 5-hydroxydecanoic acid (5HD), an m-KATP channel blocker, at 10 mg/kg, before high-dose fasudil. Myocardial infarct size was expressed as a percentage of area at risk (AAR).ResultsUnder normoglycemia, low-dose and high-dose fasudil and diazoxide reduced myocardial infarct size (23 ± 8%, 21 ± 9% and 21 ± 10% of AAR, respectively) compared with that in the control (42 ± 7%). Under hyperglycemia, low-dose fasudil (40 ± 11%) and diazoxide (44 ± 14%) could not exert this beneficial effect, but high-dose fasudil reduced myocardial infarct size in the same manner as under normoglycemia (21 ± 13%). 5HD prevented fasudil-induced reduction of myocardial infarct size (42 ± 13%).ConclusionFasudil induces PostC against myocardial infarction via activation of m-KATP channels in the rat. Although hyperglycemia attenuates the PostC, high-dose fasudil can restore cardioprotection.


Journal of Neurosurgical Anesthesiology | 2008

Admission microalbuminuria and neurologic outcomes in intensive care unit patients with spontaneous intracerebral hemorrhage.

Yoshiaki Terao; Kosuke Miura; Taiga Ichinomiya; Ushio Higashijima; Makoto Fukusaki; Koji Sumikawa

This study was performed to determine the prevalence and the prognostic significance of microalbuminuria in patients admitted to intensive care unit (ICU) after spontaneous intracerebral hemorrhage (ICH). From May 2004 to April 2006, we studied 59 consecutive ICH patients verified using computed tomography and admitted to our ICU within a day after stroke. General clinical, neurologic data, and Glasgow Coma Scale (GCS) were recorded at admission to ICU. Urine was collected at admission to ICU for measuring the urinary microalbumin/creatinine ratio. At hospital discharge, neurologic outcome was assessed using Glasgow Outcome Scale. Among 59 patients, 37 (63%) had unfavorable neurologic outcomes (death, persistent vegetative state, and severe disability). The prevalence rate of microalbuminuria was 85% [95% confidence interval (CI), 76-94]. The areas under the receiver operator characteristic curves showed that the urinary microalbumin/creatinine ratio [0.81 (95% CI, 0.70-0.92)] and the GCS score [0.78 (95% CI, 0.66-0.90)] at admission were significant predictors of unfavorable neurologic outcome at hospital discharge. The threshold value, sensitivity, specificity, and likelihood ratio for the urinary microalbumin/creatinine ratio were 200 mg/g, 51% (95% CI, 39-64), 96% (95% CI, 90-100), and 11.3 (95% CI, 7.9-16.0); and those for the GCS score were 11, 46% (95% CI, 36-61), 96% (95% CI, 90-100), and 10.1 (95% CI, 7.2-14.1), respectively. This study confirmed a high prevalence of microalbuminuria in ICH patients in ICU, and suggested that the urinary microalbumin/creatinine ratio >200 mg/g was comparable to the GCS score <11 at admission to the ICU with regard to its prognostic characteristics after ICH.


Journal of Anesthesia | 2015

Pecs block for anesthesia in breast surgery of the elderly

Hiroaki Murata; Taiga Ichinomiya; Tetsuya Hara

1. Bashandy GM, Abbas DN. Pectoral nerves I and II blocks in multimodal analgesia for breast cancer surgery: a randomized clinical trial. Reg Anesth Pain Med. 2015;40:68–74. 2. Blanco R, Fajardo M, Parras Maldonado T. Ultrasound description of Pecs II (modified Pecs I): a novel approach to breast surgery. Rev Esp Anestesiol Reanim. 2012;59:470–5.


Journal of Critical Care | 2017

Intestinal fatty acid-binding protein level as a predictor of 28-day mortality and bowel ischemia in patients with septic shock: A preliminary study

Motohiro Sekino; Hiroyuki Funaoka; Shuntaro Sato; Kyoko Okada; Haruka Inoue; Rintaro Yano; Sojiro Matsumoto; Taiga Ichinomiya; Ushio Higashijima; Shuhei Matsumoto; Tetsuya Hara

Purpose: We sought to evaluate the levels of intestinal fatty acid‐binding protein (I‐FABP), a biomarker of enterocyte injury, as a predictor of 28‐day mortality and bowel ischemia in septic shock patients. Material and methods: In this preliminary prospective observational study, 57 adult septic shock patients under mechanical ventilation were enrolled. Serum I‐FABP levels and prognostic biomarkers were recorded upon intensive care unit (ICU) admission. Results: The overall 28‐day mortality rate of participants was 23% (13/57). Non‐survivors displayed significantly higher lactate (p = 0.009), I‐FABP (p = 0.012), and N‐terminal pro‐B‐type natriuretic peptide (p = 0.039) levels compared to survivors. Only I‐FABP was associated with 28‐day mortality (odds ratio, 1.036; 95% confidence interval, 1.003–1.069; p = 0.031) in a multiple logistic regression analysis adjusted for the Acute Physiology and Chronic Health Evaluation II score. When divided into low and high I‐FABP groups based on the optimum cut‐off value of 19.0 ng/mL for predicting 28‐day mortality, high‐I‐FABP patients had a significantly higher incidence of non‐occlusive mesenteric ischemia (NOMI) (2% [1/43] vs 29% [4/14]; p = 0.011). Conclusions: I‐FABP level at ICU admission can serve as a predictor of 28‐day mortality in septic shock patients and is associated with the incidence of NOMI. HighlightsWe studied intestinal fatty acid‐binding protein and mortality in septic shock.I‐FABP level was a predictor of 28‐day mortality in septic shock patients.Predictive ability of ICU baseline I‐FABP in septic shock patients was evaluated.


Neurocritical Care | 2010

QTc interval and neurological outcomes in aneurysmal subarachnoid hemorrhage.

Taiga Ichinomiya; Yoshiaki Terao; Kosuke Miura; Ushio Higashijima; Tomomi Tanise; Makoto Fukusaki; Koji Sumikawa


Journal of Anesthesia | 2012

Comparison between propofol and dexmedetomidine in postoperative sedation after extensive cervical spine surgery

Yoshiaki Terao; Taiga Ichinomiya; Ushio Higashijima; Tomomi Tanise; Kosuke Miura; Makoto Fukusaki; Koji Sumikawa


Journal of Anesthesia | 2016

The effects of intravenous anesthetics on QT interval during anesthetic induction with sevoflurane

Yoshiaki Terao; Ushio Higashijima; Tomomi Toyoda; Taiga Ichinomiya; Makoto Fukusaki; Tetsuya Hara


CIRCULATION CONTROL | 2012

Fasudil Administered during Early Reperfusion Protects against Myocardial Infarction through Activation of PI3K/Akt/NOS Pathway in Rats

Takuji Maekawa; Sungsam Cho; Taiga Ichinomiya; Shinya Tosaka; Shuhei Matsumoto; Itsuko Shibata; Tetsuya Hara; Koji Sumikawa


Shock | 2018

Association Between Macroscopic Tongue Ischemia and Enterocyte Injury and Poor Outcome in Patients with Septic Shock: A Preliminary Observational Study

Motohiro Sekino; Hiroyuki Funaoka; Shuntaro Sato; Kyoko Okada; Haruka Inoue; Rintaro Yano; Sojiro Matsumoto; Taiga Ichinomiya; Ushio Higashijima; Shuhei Matsumoto; Tetsuya Hara


Journal of Surgical Research | 2018

Intestinal fatty acid–binding protein levels in patients with chronic renal failure

Kyoko Okada; Motohiro Sekino; Hiroyuki Funaoka; Shuntaro Sato; Taiga Ichinomiya; Hiroaki Murata; Takuji Maekawa; Masaharu Nishikido; Kiyoyuki Eishi; Tetsuya Hara

Collaboration


Dive into the Taiga Ichinomiya's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge